When you give to The Ohio State University Wexner Medical Center, you’re helping improve lives
We’re committed to making advancements in research, education and patient care that will have an impact throughout Ohio and the world.
Ways to Give
Discovery & Innovation
NIH funds five-year Ohio State COVID-19 study to find new treatments and prevent long COVID
The National Institutes of Health (NIH) has granted $15 million to a long-term study at The Ohio State University that explores the role a single molecule plays in triggering severe damage in the body during infection by the SARS-CoV-2 virus that causes COVID-19.
A 2022 Ohio State study suggests that blocking this enzyme might reduce inflammation, tissue injury and blood clots in the lungs, therefore preventing severe disease from COVID-19. The new study would broaden the research to other areas of the body and, eventually, offer the scientific community a better understanding of what’s happening to every cell and organ during SARS-CoV-2, says Amal Amer, MD, PhD, a professor of Microbial Infection and Immunity at The Ohio State University College of Medicine and the contact principal investigator of the NIH grant.
Topics
Related websites
Articles on Discovery & Innovation
Treatment Advances
FDA-approved MISHA knee system offers new knee replacement alternative
A knee surgical system offers an alternative to knee replacement surgery for people experiencing knee pain. Ohio State was the first in the country to install a shock absorber device in the knee that is now FDA-approved.
Treatment Advances
Figuring out why some skin rashes turn deadly
Dermatologists Dr. Benjamin Kaffenberger and Dr. Abraham Korman are at the forefront of developing new diagnostic tools and treatments for life-threatening rashes. Their work is paving the way for better health outcomes and, potentially, FDA-approved treatments.